Parameters for pesticide QSAR and PBPK/PD models for human risk assessment /
| Corporate Authors: | , |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Language Notes: | English. |
| Published: |
Washington, DC :
American Chemical Society,
©2012.
|
| Series: | ACS symposium series ;
1099. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Parameters for pesticide QSAR and PBPK/PD models to inform human risk assessments
- Chiral chemistry and toxicity assessments for pyrethroid pesticides
- Direct chiral separation of pyrethroid isomers by HPLC with chiral stationary phases
- Biotransformation and enzymes responsible for metabolism of pyrethroids in mammals
- Characterization of potential age-related differences in pyrethroid pharmacokinetics
- 15 factors of percutaneous penetration of pesticides
- Percutaneous absorption of pesticide formulations
- Human metabolic interactions of pesticides : inhibition, induction and activation
- Paraoxonase 1 (PON1) status in risk assessment for organophosphate exposure and pharmacokinetics
- Carboxylesterases : a multifunctional enzyme involved in pesticide and lipid metabolism
- Behavioral changes in adult and young rats as indications of cholinesterase inhibition
- Comparison of esterase sensitivity, metabolic efficiency, and toxicity levels of two organophosphorus insecticides, parathion and chlorpyrifos
- Regional brain dosimetry for the organophosphorus insecticide chlorpyrifos in the preweanling rat
- Pyrethroid actions on sodium channels : isoform and species specificity
- In vitro and in vivo experimental data for development and use of pharmacokinetic models for in vitro to in vivo extrapolation of pyrethroid insecticides
- In silico strategies for modeling stereoselective metabolism of pyrethroids
- Quantitative structure-activity relationships for organophosphate enzyme inhibition
- Computational approaches for developing informative prior distributions for bayesian calibration of PBPK models
- Use of cytochrome P450-specific parameters and human biomarker data to develop a human physiologically based pharmacokinetic/pharmacodynamic model for dermal chlorpyrifos exposure
- Use of in vitro data in PBPK models : an example of in vitro to in vivo extrapolation with carbaryl.